OnKure Therapeutics to Present at Upcoming Leerink and Stifel Investor Conferences
OnKure Therapeutics, Inc. (Nasdaq: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel ...
Werewolf Therapeutics to Present at the 2025 Leerink Partners Global Biopharma Conference
Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...
Hosted on MSN2h
Leerink Partners Downgrades Pliant Therapeutics (PLRX)
Fintel reports that on March 3, 2025, Leerink Partners downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...
Neumora Therapeutics to Present at Leerink Global Healthcare Conference
Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced ...
Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference
CLEVELAND, March 04, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Abeona’s Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., will present at the Leerink ...
DENTSPLY SIRONA Q1 EPS Forecast Reduced by Leerink Partnrs
Stock analysts at Leerink Partnrs dropped their Q1 2025 earnings per share estimates for shares of DENTSPLY SIRONA in a ...
Q1 Earnings Estimate for argenx Issued By Leerink Partnrs
Equities researchers at Leerink Partnrs issued their Q1 2025 EPS estimates for argenx in a research report issued to clients ...
Walgreens could go private in deal with Sycamore Partners
The Financial Times is reporting that Walgreens Boots Alliance would be split three ways if Sycamore Partners buys out the ...
Illumina Stock Drops as China Bans Imports of Gene Sequencing Technology
Illumina stock slid on Tuesday after China banned imports of the biotech’s gene sequencing machines as part of a broader ...